Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shu-Guang Su

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Cancer Management and Research|December 13, 2018
ESCO2 inhibits tumor metastasis via transcriptionally repressing MMP2 in colorectal cancerXiong-Bo Guo, Bin Huang, Ying-Hua Pan, et al.
Biochemical and Biophysical Research Communications|September 7, 2015
BLZF1 expression is of prognostic significance in hepatocellular carcinomaRun-Yue Huang, Shu-Guang Su, Dan-Chun Wu, et al.
Translational Oncology|July 22, 2018
CBX1 Indicates Poor Outcomes and Exerts Oncogenic Activity in Hepatocellular CarcinomaYu-Feng Yang, Ying-Hua Pan, Qiu-Hong Tian, et al.
Frontiers in Oncology|February 22, 2021
An E2F1/DDX11/EZH2 Positive Feedback Loop Promotes Cell Proliferation in Hepatocellular CarcinomaShu-Guang Su, Qiu-Li Li, Mei-Fang Zhang, et al.
Biochemical and Biophysical Research Communications|June 22, 2018
UBE2S enhances the ubiquitination of p53 and exerts oncogenic activities in hepatocellular carcinomaYing-Hua Pan, Mei Yang, Li-Ping Liu, et al.
Gynecologic Oncology|October 24, 2015
Prognostic factors of regression and relapse of complex atypical hyperplasia and well-differentiated endometrioid carcinoma with conservative treatmentYu-Feng Yang, Ying-Yang Liao, Xian-Lian Liu, et al.
The International Journal of Biochemistry & Cell Biology|December 30, 2019
PRMT6 promotes endometrial cancer via AKT/mTOR signaling and indicates poor prognosisNan Jiang, Qiu-Li Li, Wenwei Pan, et al.
The International Journal of Biochemistry & Cell Biology|September 5, 2017
miR-107-mediated decrease of HMGCS2 indicates poor outcomes and promotes cell migration in hepatocellular carcinomaShu-Guang Su, Mei Yang, Mei-Fang Zhang, et al.
Cancer Science|October 27, 2024
PPM1G-mediated TBL1X mRNA splicing promotes cell migration in hepatocellular carcinomaLiling Hu, Xinyu Shi, Xiaoyi Yuan, et al.
Oncotarget|May 19, 2016
HEY2, a target of miR-137, indicates poor outcomes and promotes cell proliferation and migration in hepatocellular carcinomaDan-Chun Wu, Mei-Fang Zhang, Shu-Guang Su, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Cancer Management and Research|December 13, 2018
ESCO2 inhibits tumor metastasis via transcriptionally repressing MMP2 in colorectal cancerXiong-Bo Guo, Bin Huang, Ying-Hua Pan, et al.
Biochemical and Biophysical Research Communications|September 7, 2015
BLZF1 expression is of prognostic significance in hepatocellular carcinomaRun-Yue Huang, Shu-Guang Su, Dan-Chun Wu, et al.
Translational Oncology|July 22, 2018
CBX1 Indicates Poor Outcomes and Exerts Oncogenic Activity in Hepatocellular CarcinomaYu-Feng Yang, Ying-Hua Pan, Qiu-Hong Tian, et al.
Frontiers in Oncology|February 22, 2021
An E2F1/DDX11/EZH2 Positive Feedback Loop Promotes Cell Proliferation in Hepatocellular CarcinomaShu-Guang Su, Qiu-Li Li, Mei-Fang Zhang, et al.
Biochemical and Biophysical Research Communications|June 22, 2018
UBE2S enhances the ubiquitination of p53 and exerts oncogenic activities in hepatocellular carcinomaYing-Hua Pan, Mei Yang, Li-Ping Liu, et al.
Gynecologic Oncology|October 24, 2015
Prognostic factors of regression and relapse of complex atypical hyperplasia and well-differentiated endometrioid carcinoma with conservative treatmentYu-Feng Yang, Ying-Yang Liao, Xian-Lian Liu, et al.
The International Journal of Biochemistry & Cell Biology|December 30, 2019
PRMT6 promotes endometrial cancer via AKT/mTOR signaling and indicates poor prognosisNan Jiang, Qiu-Li Li, Wenwei Pan, et al.
The International Journal of Biochemistry & Cell Biology|September 5, 2017
miR-107-mediated decrease of HMGCS2 indicates poor outcomes and promotes cell migration in hepatocellular carcinomaShu-Guang Su, Mei Yang, Mei-Fang Zhang, et al.
Cancer Science|October 27, 2024
PPM1G-mediated TBL1X mRNA splicing promotes cell migration in hepatocellular carcinomaLiling Hu, Xinyu Shi, Xiaoyi Yuan, et al.
Oncotarget|May 19, 2016
HEY2, a target of miR-137, indicates poor outcomes and promotes cell proliferation and migration in hepatocellular carcinomaDan-Chun Wu, Mei-Fang Zhang, Shu-Guang Su, et al.
Pageof 2